A compound management facility at the Wilmington plant opened in 2004. The headquarters will stay.The drugmaker AstraZeneca said Monday that it would cut or move 1,200 jobs from its facility in Wilmington by the end of 2015, with the research and development ...
[Published Philadelphia Inquirer - Mar 19 2013]